The Effectiveness of Electrical Vestibular Stimulation (VeNS) on Symptoms of Anxiety: Study Protocol of a Randomized, Double-Blinded, Sham-Controlled Trial

Teris Cheung (), Joyce Yuen Ting Lam, Kwan Hin Fong, Yuen Shan Ho, Alex Ho, Calvin Pak-Wing Cheng, Julie Sittlington, Yu-Tao Xiang and Tim Man Ho Li ()
Additional contact information
Teris Cheung: School of Nursing, The Hong Kong Polytechnic University, Hong Kong SAR, China
Joyce Yuen Ting Lam: School of Nursing, The Hong Kong Polytechnic University, Hong Kong SAR, China
Kwan Hin Fong: School of Nursing, The Hong Kong Polytechnic University, Hong Kong SAR, China
Yuen Shan Ho: School of Nursing, The Hong Kong Polytechnic University, Hong Kong SAR, China
Alex Ho: Integrated Services for Persons with Disabilities, Christian Family Service Centre, Hong Kong SAR, China
Calvin Pak-Wing Cheng: Department of Psychiatry, The University of Hong Kong, Hong Kong SAR, China
Julie Sittlington: School of Biomedical Sciences, Ulster University, Coleraine BT52 1SA, UK
Yu-Tao Xiang: Department of Public Health and Medicinal Administration, Faculty of Health Sciences, University of Macau, Macau SAR, China
Tim Man Ho Li: Department of Psychiatry, The Chinese University of Hong Kong, Hong Kong SAR, China

IJERPH, 2023, vol. 20, issue 5, 1-12

Abstract: The prevalence of symptoms of anxiety is increasing, especially during the COVID-19 pandemic. A home use transdermal neurostimulation device might help to minimize the severity of anxiety disorder. To the best of our knowledge, there is no clinical trial using transdermal neurostimulation to treat individuals with symptoms of anxiety in Asia. This gives us the impetus to execute the first study which aims at evaluating the efficacy of Electrical Vestibular Stimulation (VeNS) on anxiety in Hong Kong. This study proposes a two-armed, double-blinded, randomized, sham-controlled trial including the active VeNS and sham VeNS group. Both groups will be measured at baseline (T1), immediately after the intervention (T2), and at the 1-month (T3) and 3-month follow-up (T4). A total of 66 community-dwelling adults aged 18 to 60 with anxiety symptoms will be recruited in this study. All subjects will be computer randomised into either the active VeNS group or the sham VeNS group in a 1:1 ratio. All subjects in each group will receive twenty 30 min VeNS sessions during weekdays, which will be completed in a 4-week period. Baseline measurements and post-VeNS evaluation of the psychological outcomes (i.e., anxiety, insomnia, and quality of life) will also be conducted on all participants. The 1-month and 3-month follow-up period will be used to assess the long-term sustainability of the VeNS intervention. For statistical analysis, ANOVA with repeated measures will be used to analyze data. Missing data were managed with multiple mutations. The level of significance will be set to p < 0.05. Results of this study will be used to determine whether this VeNS device can be considered as a self-help technological device to reduce perceived anxiety in the general population in the community setting. This clinical Trial was registered with the Clinical Trial government, identifier: NCT04999709.

Keywords: vestibular stimulation; rct; anxiety; non-invasive brain stimulation; efficacy (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/20/5/4218/pdf (application/pdf)
https://www.mdpi.com/1660-4601/20/5/4218/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:20:y:2023:i:5:p:4218-:d:1081729

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().